Overview
- Carly Stokes, a 40-year-old NHS healthcare assistant, says she will take extra shifts after her monthly Mounjaro cost rises from £229 to £319 via Voy.
- Eli Lilly has implemented a UK price increase of up to 170% from September and says it is working with private providers to maintain affordability and with government to expand NHS access.
- Voy’s chief medical officer said the service can support clinically supervised switches to Wegovy for suitable patients at a more accessible price point.
- Stokes credits Mounjaro with helping her lose six stone and reverse pre-diabetes by curbing binge eating, and she fears regaining weight if she stops treatment.
- NHS England declined to comment on the case, and Stokes said she went private after hearing it was very hard to access the drug through the NHS.